A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors
NCT ID: NCT00588107
Last Updated: 2014-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
374 participants
INTERVENTIONAL
2005-09-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in the Web condition received access to an interactive Web site that focuses on survivorship, health, and smoking. Participants in the Materials control group received tailored and targeted print materials.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Web site access
Web intervention- and access to pharmacotherapy
Web Intervention
Receives pharmacotherapy and access to an interactive Web site (Web condition). The Web site will offer tailored intervention messages and strategies in an interactive format that is much less labor-intensive and costly than the prior PFH peer telephone counseling intervention.
print materials
Receives tailored print materials and access to pharmacotherapy (Materials condition)
print materials
tailored print materials designed to aid in smoking reduction and cessation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Web Intervention
Receives pharmacotherapy and access to an interactive Web site (Web condition). The Web site will offer tailored intervention messages and strategies in an interactive format that is much less labor-intensive and costly than the prior PFH peer telephone counseling intervention.
print materials
tailored print materials designed to aid in smoking reduction and cessation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently be ≥ 18 years of age and ≤ 55 years of age
* 2 or more years out of cancer treatment
* Be mentally capable of providing informed consent
* Be reachable by telephone for screening and survey completion
* Be a current smoker (defined as having taken one puff of a cigarette in the last 30 days)
* Fluent in English
Exclusion Criteria
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
St. Jude Children's Research Hospital
OTHER
Princess Margaret Hospital, Canada
OTHER
The Hospital for Sick Children
OTHER
University of Massachusetts, Amherst
OTHER
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Emmons, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen M Emmons, PhD
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
DFCI
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
de Moor JS, Puleo E, Ford JS, Greenberg M, Hodgson DC, Tyc VL, Ostroff J, Diller LR, Levy AG, Sprunck-Harrild K, Emmons KM. Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study. BMC Cancer. 2011 May 11;11:165. doi: 10.1186/1471-2407-11-165.
Nagler RH, Puleo E, Sprunck-Harrild K, Emmons KM. Internet use among childhood and young adult cancer survivors who smoke: implications for cessation interventions. Cancer Causes Control. 2012 Apr;23(4):647-52. doi: 10.1007/s10552-012-9926-9. Epub 2012 Feb 28.
Tyc VL, Puleo E, Emmons K, de Moor JS, Ford JS. Smoking Restrictions Among Households of Childhood and Young Adult Cancer Survivors: Implications for Tobacco Control Efforts. J Adolesc Young Adult Oncol. 2013 Mar;2(1):17-24. doi: 10.1089/jayao.2012.0019.
Nagler RH, Puleo E, Sprunck-Harrild K, Viswanath K, Emmons KM. Health media use among childhood and young adult cancer survivors who smoke. Support Care Cancer. 2014 Sep;22(9):2497-507. doi: 10.1007/s00520-014-2236-x. Epub 2014 Apr 13.
Ford JS, Puleo E, Sprunck-Harrild K, deMoor J, Emmons KM. Perceptions of risk among childhood and young adult cancer survivors who smoke. Support Care Cancer. 2014 Aug;22(8):2207-17. doi: 10.1007/s00520-014-2165-8.
Emmons KM, Sprunck-Harrild K, Puleo E, de Moor J. Provider advice about smoking cessation and pharmacotherapy among cancer survivors who smoke: practice guidelines are not translating. Transl Behav Med. 2013 Jun;3(2):211-7. doi: 10.1007/s13142-013-0202-7.
Emmons KM, Puleo E, Sprunck-Harrild K, Ford J, Ostroff JS, Hodgson D, Greenberg M, Diller L, de Moor J, Tyc V. Partnership for health-2, a web-based versus print smoking cessation intervention for childhood and young adult cancer survivors: randomized comparative effectiveness study. J Med Internet Res. 2013 Nov 5;15(11):e218. doi: 10.2196/jmir.2533.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05-032
Identifier Type: -
Identifier Source: org_study_id